Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Endolumenal Partial Myotomy for Esophageal Motility Disorders

for
Esophageal Motility Disorders
Location: Portland OR
Sponsor: The Oregon Clinic

Sex: All

Age: 18 - 70+

Code: NCT01302301

Phase 2, Recruiting

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

for
Small Cell Lung Cancer (SCLC),
Location: Portland OR, Seattle WA, Duarte CA, Los Angeles CA,
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05652686

Phase 1, Phase 2, Recruiting

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

for
Carotid Artery Calcification, Carotid Artery Diseases
Location: Portland OR, San Francisco CA, Rancho Mirage CA,
Sponsor: Shockwave Medical, Inc.

Sex: All

Age: 18+

Code: NCT07062471

Recruiting

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

for
Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer,
Location: Portland OR, Los Angeles CA, Aurora CO, Minneapolis MN,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07024784

Phase 2, Recruiting

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

for
Prostate Cancer
Location: Portland OR, Atlanta GA, Hackensack NJ
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07543055

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Portland OR, Dallas TX, Skokie IL, Ann Arbor MI,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06731478

Phase 3, Recruiting

Clinical Procedures to Support Research in ALS

for
Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia,
Location: Portland OR, San Francisco CA, Palo Alto CA, Irvine CA,
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT03489278

Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Portland OR, Olympia WA, Puyallup WA, Bonney Lake WA,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase 2, Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

for
Locoregional Recurrence,
Location: Portland OR, Phoenix AZ, Albuquerque NM, Omaha NE,
Sponsor: Oana Danciu

Sex: All

Age: 18+

Code: NCT05467891

Phase 2, Recruiting
New

A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Portland OR, Salt Lake City UT, Los Angeles CA,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07542704

Phase 1, Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Portland OR, Clovis CA, Edmonton, Los Angeles CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase 1, Phase 2, Recruiting

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

for
Advanced Solid Tumor, Non Small Cell Lung Cancer,
Location: Portland OR, Los Angeles CA, Beverly Hills CA,
Sponsor: Synthekine

Sex: All

Age: 18+

Code: NCT05098132

Phase 1, Phase 2, Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Portland OR, Eugene OR, Billings MT, Los Angeles CA,
Sponsor: Incyte Corporation

Sex: Female

Age: 18+

Code: NCT07214779

Phase 3, Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

for
Platinum-resistant Ovarian Cancer, Testicular Cancer,
Location: Portland OR, Denver CO, Omaha NE, Dallas TX,
Sponsor: Context Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06515613

Phase 1, Recruiting

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

for
Advanced Solid Tumor, Cutaneous Tumor, Subcutaneous Tumor,
Location: Portland OR, Toronto, Pittsburgh PA, Bethesda MD,
Sponsor: Ankyra Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06171750

Phase 1, Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Portland OR, San Francisco CA, West Valley City UT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase 1, Phase 2, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Portland OR, Seattle WA, Vancouver, San Francisco CA,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase 3, Recruiting

Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors

for
Solid Tumor, Cancer Metastatic
Location: Portland OR, Woburn MA
Sponsor: CanWell Pharma Inc.

Sex: All

Age: 18 - 70+

Code: NCT04987112

Phase 1, Recruiting

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Location: Portland OR, Minneapolis MN, Green Bay WI, Hinsdale IL,
Sponsor: Luminate Medical, Inc.

Sex: All

Age: 18+

Code: NCT07142304

Recruiting

First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors

for
Select Advanced Solid Tumors
Location: Portland OR, Philadelphia PA
Sponsor: CDR-Life AG

Sex: All

Age: 18+

Code: NCT06402201

Phase 1, Recruiting